Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin). (Q37623853)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin). |
scientific article |
Statements
1 reference
Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin). (English)
1 reference
Paul M Ridker
1 reference
Jay Wohlgemuth
1 reference
Samia Mora
1 reference
Feras M Hantash
1 reference
Amit V Khera
1 reference
Brendan M Everett
1 reference
Michael P Caulfield
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference